To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy
Assessing Cosopt Switch Patients
To assess the safety and efficacy of a cohort of patients switched to the dorzolamide/timolol maleate fixed combination because they are insufficiently controlled on latanoprost monotherapy.
To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.
100 Clinical Results associated with Pharmaceutical Research Network
0 Patents (Medical) associated with Pharmaceutical Research Network
100 Deals associated with Pharmaceutical Research Network
100 Translational Medicine associated with Pharmaceutical Research Network